Dexamethasone inhibits in vivo tumor growth by the alteration of bone marrow CD11b+ myeloid cells

International Immunopharmacology

Volumn 21, Issue 2, 2014, Pages 494-500

  Moon, Eun Yi ^a   Ryu, Yun Kyoung ^a   Lee, Geun Hee ^a  

^a Sejong University   (South Korea)

Author keywords

Bone marrow cells; Dexamethasone; MDSC; Tumor growth

Indexed keywords

CD11B ANTIGEN; DEXAMETHASONE; ANTIINFLAMMATORY AGENT; CHEMOKINE RECEPTOR; GR-1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW CELL; CANCER INHIBITION; CANCER REGRESSION; CANCER SURGERY; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; FEMALE; GRANULOCYTE; IN VIVO STUDY; LIFESPAN; LUNG METASTASIS; LYMPHOCYTE; MELANOMA; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BONE MARROW; C57BL MOUSE; DIET THERAPY; DRUG EFFECTS; EXPERIMENTAL MELANOMA; METABOLISM;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIGENS, CD11B; BONE MARROW; BONE MARROW CELLS; DEXAMETHASONE; FEMALE; GRANULOCYTES; LYMPHOCYTES; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MONOCYTES; MYELOID CELLS; RECEPTORS, CHEMOKINE;

EID: 84903582645     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2014.06.006     Document Type: Article

References (32)

1. I. Kim, H. Uchiyama, D. Chauhan, and K.C. Anderson Cell surface expression and functional significance of adhesion molecules on human myeloma-derived cell lines Br J Haematol 87 1994 483 493 (Pubitemid 24230012)
2. Y. Shaked, and E.E. Voest Bone marrow derived cells in tumor angiogenesis and growth: are they the good, the bad or the evil? Biochim Biophys Acta 1796 2009 1 4
3. R.N. Kaplan, B. Psaila, and D. Lyden Bone marrow cells in the 'pre-metastatic niche': within bone and beyond Cancer Metastasis Rev 25 2006 521 529 (Pubitemid 46071861)
4. X.Z. Wu, D. Chen, and G.R. Xie Bone marrow-derived cells: roles in solid tumor. Minireview Neoplasma 54 2007 1 6
5. G.O. Ahn, and J.M. Brown Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells Cancer Cell 13 2008 193 205 (Pubitemid 351318369)
6. J. Laurent, E.F. Hull, C. Touvrey, F. Kuonen, Q. Lan, and G. Lorusso et al. Proangiogenic factor PlGF programs CD11b(+) myelomonocytes in breast cancer during differentiation of their hematopoietic progenitors Cancer Res 71 2011 3781 3791
7. L. Yang, L.M. DeBusk, K. Fukuda, B. Fingleton, B. Green-Jarvis, and Y. Shyr et al. Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis Cancer Cell 6 2004 409 421 (Pubitemid 39361441)
8. S. Hiratsuka, A. Watanabe, H. Aburatani, and Y. Maru Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis Nat Cell Biol 8 2006 1369 1375 (Pubitemid 44835111)
9. M.A. Arnaout Structure and function of the leukocyte adhesion molecules CD11/CD18 Blood 75 1990 1037 1050 (Pubitemid 20086807)
10. G.O. Ahn, D. Tseng, C.H. Liao, M.J. Dorie, A. Czechowicz, and J.M. Brown Inhibition of Mac-1 (CD11b/CD18) enhances tumor response to radiation by reducing myeloid cell recruitment Proc Natl Acad Sci U S A 107 2010 8363 8368
11. P. Serafini, I. Borrello, and V. Bronte Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression Semin Cancer Biol 16 2006 53 65 (Pubitemid 43139709)
12. V. Bronte, D.B. Chappell, E. Apolloni, A. Cabrelle, M. Wang, and P. Hwu et al. Unopposed production of granulocyte-macrophage colony-stimulating factor by tumors inhibits CD8 + T cell responses by dysregulating antigen-presenting cell maturation J Immunol 162 1999 5728 5737 (Pubitemid 29314923)
13. I. Marigo, L. Dolcetti, P. Serafini, P. Zanovello, and V. Bronte Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells Immunol Rev 222 2008 162 179 (Pubitemid 351430364)
14. D.I. Gabrilovich, V. Bronte, S.H. Chen, M.P. Colombo, A. Ochoa, and S. Ostrand-Rosenberg et al. The terminology issue for myeloid-derived suppressor cells Cancer Res 67 425 2007 [author reply 6]
15. P.A. Volden, and S.D. Conzen The influence of glucocorticoid signaling on tumor progression Brain Behav Immun 30 2013 S26 S31 [Suppl.]
16. U. Rozovski, M.J. Keating, and Z. Estrov Targeting inflammatory pathways in chronic lymphocytic leukemia Crit Rev Oncol Hematol 88 2013 655 666
17. C.A. Mikosz, D.R. Brickley, M.S. Sharkey, T.W. Moran, and S.D. Conzen Glucocorticoid receptor-mediated protection from apoptosis is associated with induction of the serine/threonine survival kinase gene, sgk-1 J Biol Chem 276 2001 16649 16654
18. Y. Huang, K.R. Johnson, J.S. Norris, and W. Fan Nuclear factor-kappaB/IkappaB signaling pathway may contribute to the mediation of paclitaxel-induced apoptosis in solid tumor cells Cancer Res 60 2000 4426 4432 (Pubitemid 32103621)
19. C. Zhang, T. Wenger, J. Mattern, S. Ilea, C. Frey, and P. Gutwein et al. Clinical and mechanistic aspects of glucocorticoid-induced chemotherapy resistance in the majority of solid tumors Cancer Biol Ther 6 2007 278 287 (Pubitemid 46641636)
20. G. Francia, W. Cruz-Munoz, S. Man, P. Xu, and R.S. Kerbel Mouse models of advanced spontaneous metastasis for experimental therapeutics Nat Rev Cancer 11 2011 135 141
21. F. Balkwill, K.A. Charles, and A. Mantovani Smoldering and polarized inflammation in the initiation and promotion of malignant disease Cancer Cell 7 2005 211 217 (Pubitemid 40568680)
22. J. Condeelis, and J.W. Pollard Macrophages: obligate partners for tumor cell migration, invasion, and metastasis Cell 124 2006 263 266 (Pubitemid 43121975)
23. A. Mantovani, P. Allavena, A. Sica, and F. Balkwill Cancer-related inflammation Nature 454 2008 436 444
24. L.S. van Rijt, H. Kuipers, N. Vos, D. Hijdra, H.C. Hoogsteden, and B.N. Lambrecht A rapid flow cytometric method for determining the cellular composition of bronchoalveolar lavage fluid cells in mouse models of asthma J Immunol Methods 288 2004 111 121 (Pubitemid 38739257)
25. A. Go, Y.K. Ryu, J.W. Lee, and E.Y. Moon Cell motility is decreased in macrophages activated by cancer cell-conditioned medium Biomol Ther 21 2013 481 486
26. D.M. Mosser, and J.P. Edwards Exploring the full spectrum of macrophage activation Nat Rev Immunol 8 2008 958 969
27. B.Z. Qian, and J.W. Pollard Macrophage diversity enhances tumor progression and metastasis Cell 141 2010 39 51
28. A. Sica, and V. Bronte Altered macrophage differentiation and immune dysfunction in tumor development J Clin Invest 117 2007 1155 1166 (Pubitemid 46718400)
29. K. Movahedi, M. Guilliams, J. Van den Bossche, R. Van den Bergh, C. Gysemans, and A. Beschin et al. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity Blood 111 2008 4233 4244
30. R. Zhou, P.L. He, Y.X. Ren, W.H. Wang, R.Y. Zhou, and H. Wan et al. Myeloid suppressor cell-associated immune dysfunction in CSA1M fibrosarcoma tumor-bearing mice Cancer Sci 98 2007 882 889 (Pubitemid 46691827)
31. G. Gallina, L. Dolcetti, P. Serafini, C. De Santo, I. Marigo, and M.P. Colombo et al. Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8 + T cells J Clin Invest 116 2006 2777 2790 (Pubitemid 44511641)
32. S. Kusmartsev, and D.I. Gabrilovich STAT1 signaling regulates tumor-associated macrophage-mediated T cell deletion J Immunol 174 2005 4880 4891